Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Film Tells Children There Are ‘over 100’ Genders

BBC has created a film aimed at young children explaining…
Read more

Xi Takes Victory Lap at Davos

XI Jinping celebrates in victory a year later after the global…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Israel Opens Embassy in UAE

Israel recently opened its embassy in the United Arab Emirates.…
Read more